ASX - By Stock
|
ADR |
Re:
Ann: Placement and Entitlement Offer to raise up to $8.37 million
|
|
Bloky
|
18 |
4.0K |
7 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
18
|
4.0K
|
7
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Organisational Changes
|
|
Bloky
|
11 |
4.8K |
22 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
11
|
4.8K
|
22
|
|
ASX - By Stock
|
ADR |
Re:
Ann: US FDA clearance of Hailie for AstraZeneca inhalers
|
|
Bloky
|
75 |
19K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
75
|
19K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: US FDA clearance of Hailie for AstraZeneca inhalers
|
|
Bloky
|
75 |
19K |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
75
|
19K
|
4
|
|
ASX - By Stock
|
ALC |
Re:
General Discussion / Social Media
|
|
Bloky
|
6.1K |
3.6M |
15 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
6.1K
|
3.6M
|
15
|
|
ASX - By Stock
|
IPD |
Re:
Media
|
|
Bloky
|
195 |
64K |
20 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
195
|
64K
|
20
|
|
ASX - By Stock
|
APX |
Re:
Appen launches solution for enterprises to customize
|
|
Bloky
|
21 |
8.8K |
2 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
21
|
8.8K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
Bloky
|
153 |
42K |
8 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
153
|
42K
|
8
|
|
ASX - By Stock
|
IPD |
Re:
Media
|
|
Bloky
|
195 |
64K |
4 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
195
|
64K
|
4
|
|
ASX - By Stock
|
APX |
Re:
Ann: Response to ASX Price Query
|
|
Bloky
|
279 |
97K |
9 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
279
|
97K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
Bloky
|
153 |
42K |
12 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
153
|
42K
|
12
|
|
ASX - By Stock
|
NAN |
Re:
Ann: Appendix 4D and Half Year Accounts
|
|
Bloky
|
1 |
797 |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1
|
797
|
1
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
Bloky
|
153 |
42K |
4 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
153
|
42K
|
4
|
|
ASX - By Stock
|
APX |
Re:
Ann: Appen 2023 Full Year Results & 2024 Outlook
|
|
Bloky
|
116 |
42K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
116
|
42K
|
7
|
|
ASX - By Stock
|
IPD |
Re:
Ann: New Clinical Practice Guidance Recommends Use of BIS
|
|
Bloky
|
65 |
11K |
7 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
65
|
11K
|
7
|
|
ASX - By Stock
|
IPD |
Re:
Ann: New Clinical Practice Guidance Recommends Use of BIS
|
|
Bloky
|
65 |
11K |
14 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
65
|
11K
|
14
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
Bloky
|
280 |
59K |
12 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
280
|
59K
|
12
|
|
ASX - By Stock
|
ADR |
Re:
Ann: New CEO Appointed - Dr Paul Mastoridis
|
|
Bloky
|
39 |
12K |
3 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
39
|
12K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
Bloky
|
280 |
59K |
9 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
280
|
59K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Notification of Results Release Dates and Conference Call
|
|
Bloky
|
31 |
7.6K |
9 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
31
|
7.6K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
Media
|
|
Bloky
|
195 |
64K |
10 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
195
|
64K
|
10
|
|
ASX - By Stock
|
IPD |
Re:
Media
|
|
Bloky
|
195 |
64K |
5 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
195
|
64K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Media
|
|
Bloky
|
195 |
64K |
11 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
195
|
64K
|
11
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Change of Director's Interest Notice - Ms Janelle Delaney
|
|
Bloky
|
3 |
1.4K |
8 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
3
|
1.4K
|
8
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Completion of Share Consolidation
|
|
Bloky
|
11 |
4.2K |
3 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
11
|
4.2K
|
3
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Monsoon Twilight Investor Briefing Presentation
|
|
Bloky
|
12 |
3.3K |
3 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
12
|
3.3K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: ImpediMed announces leadership and Board changes
|
|
Bloky
|
85 |
23K |
8 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
85
|
23K
|
8
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report - Sep-23 Qtr
|
|
Bloky
|
89 |
23K |
6 |
05/11/23 |
05/11/23 |
ASX - By Stock
|
89
|
23K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Largest US Private Payor Updates Medical Policy for BIS
|
|
Bloky
|
41 |
13K |
5 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
41
|
13K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Largest US Private Payor Updates Medical Policy for BIS
|
|
Bloky
|
41 |
13K |
3 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
41
|
13K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report - Sep-23 Qtr
|
|
Bloky
|
89 |
23K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
89
|
23K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C & Quarterly Activities Report - Sep-23 Qtr
|
|
Bloky
|
89 |
23K |
5 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
89
|
23K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Change in substantial holding
|
|
Bloky
|
11 |
3.9K |
7 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
11
|
3.9K
|
7
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
Bloky
|
816 |
342K |
4 |
12/10/23 |
12/10/23 |
Charts
|
816
|
342K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Shareholders vote for Board changes to bring in new skills
|
|
Bloky
|
12 |
4.5K |
9 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
12
|
4.5K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
Acaidia Park Responce
|
|
Bloky
|
41 |
10K |
15 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
41
|
10K
|
15
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Shareholder Conference Call
|
|
Bloky
|
44 |
13K |
2 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
44
|
13K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: 2023 Annual Report
|
|
Bloky
|
7 |
3.0K |
2 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
7
|
3.0K
|
2
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Annual Report to shareholders
|
|
Bloky
|
10 |
3.1K |
6 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
10
|
3.1K
|
6
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Accelerating Commercialisation with Largest US A&A Practice
|
|
Bloky
|
26 |
8.1K |
10 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
26
|
8.1K
|
10
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Notice received under section 249D of the Corporations Act
|
|
Bloky
|
104 |
28K |
11 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
104
|
28K
|
11
|
|
ASX - By Stock
|
ADR |
Re:
Does ADR understand their market ?
|
|
Bloky
|
73 |
20K |
0 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
73
|
20K
|
0
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Notice received under section 249D of the Corporations Act
|
|
Bloky
|
104 |
28K |
6 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
104
|
28K
|
6
|
|
ASX - By Stock
|
ADR |
Re:
Ann: Adherium enters rapid US commercialisation phase
|
|
Bloky
|
16 |
4.2K |
7 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
16
|
4.2K
|
7
|
|
ASX - By Stock
|
IPD |
Re:
Ann: First Top 5 National Payor Covering SOZO Testing
|
|
Bloky
|
29 |
10K |
13 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
29
|
10K
|
13
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
Bloky
|
816 |
342K |
8 |
04/07/23 |
04/07/23 |
Charts
|
816
|
342K
|
8
|
|
ASX - By Stock
|
NAN |
Re:
Who's playing with NAN
|
|
Bloky
|
10 |
5.5K |
3 |
04/06/23 |
04/06/23 |
ASX - By Stock
|
10
|
5.5K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: First Published Medical Policy for Bioimedance Spectroscopy
|
|
Bloky
|
18 |
6.4K |
8 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
18
|
6.4K
|
8
|
|
ASX - By Stock
|
APX |
Re:
Ann: Completion of institutional component of equity raising
|
|
Bloky
|
125 |
40K |
4 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
125
|
40K
|
4
|
|
ASX - By Stock
|
APX |
Re:
Ann: Strategy refresh and capital raising presentation
|
|
Bloky
|
116 |
44K |
15 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
116
|
44K
|
15
|
|